Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects

Documents similaires

• The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
  par: Tri Murti Andayani,, et autres
  Publié: (2009-12-01)
• A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
  par: Holman, R, et autres
  Publié: (1999)
• Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
  par: Wettergreen SA, et autres
  Publié: (2016-12-01)
• Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
  par: P. Rosenbaum, et autres
  Publié: (2002-08-01)
• Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
  par: Hui Fang, et autres
  Publié: (2020-07-01)